Perhaps you should be questioning why there have been 150% more deaths per 100,000 population in red counties than blue counties since the v*****e came out? All the scientific data says its because the republican population has not gotten the level of v******tions that the democrats and independents have! So we have a few hundred thousand less republicans around today simply because of your a*****x craziness.

It's OK to be scared, just keep your lies and conspiracy theories to yourself. You have no right to contribute to the death of others by spreading misinformation.

And how does that prove anything about your statement that in countries where nobody had a v*****e, nobody died? Just what country do you think did not have a v*****e???

Not very intelligent are you? Perhaps some real scientific analysis will help, if you have the balls to read it and discover just what a bumbling fool you are.

Here ya go, now show us you actually have a brain and read!

https://www.reuters.com/graphics/world-c****av***s-tracker-and-maps/regions/africa/

https://www.statista.com/statistics/1170530/c****av***s-deaths-in-africa/

https://www.bu.edu/sph/news/articles/2022/morgue-data-reveals-true-c****-**-death-toll-in-africa/

https://tradingeconomics.com/country-list/c****av***s-deaths?continent=africa

This is an example of what it means to be a resource-poor country,” Gill says. “We tend to think of this just in terms of health and disease, but it also reflects the ability of poorer countries to map the impact of diseases on its populations. Rather than an ‘African paradox,’ the far simpler explanation is that C****-** has affected African countries just as the v***s has everywhere else, but has gone undocumented.”

Two new studies published Wednesday report good news about the updated C****-** v*****e, with one suggesting it is more effective than the previous monovalent v*****e and the other showing that even though it targeted an earlier strain of the SARS-CoV-2 v***s, its protection is holding up against current variants.
The findings suggest the updated v*****e, which targets both the original SARS-2 v***s and the Omicron subvariants BA.4 and BA.5, is performing better than some critics of the decision to update the v*****e concluded, based on studies that only compared the levels of neutralizing antibodies each induced.
The first study, published in the New England Journal of Medicine, found the updated v*****e was significantly more effective at protecting against severe illness, hospitalization, and death from C***d than the monovalent v*****e that was previously used.
“It’s clear from this study that the bivalent booster, in that short term following administration, provides additional protection above and beyond that of the monovalent,” said Michael Osterholm, director of the University of Minnesota’s Center for Infectious Diseases Research and Policy. “I think that’s clear and this should be a reason why we can feel confident that it was the right decision to go with the bivalent v*****e.”